Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseases

Expert Review of Clinical Pharmacology
H GeertsRichard Peck

Abstract

The success rate of pharmaceutical Research & Development (R&D) is much lower compared to other industries such as micro-electronics or aeronautics with the probability of a successful clinical development to approval in central nervous system (CNS) disorders hovering in the single digits (7%). Areas covered: Inspired by adjacent engineering-based industries, we argue that quantitative modeling in CNS R&D might improve success rates. We will focus on quantitative techniques in early clinical development, such as PharmacoKinetic-PharmacoDynamic modeling, clinical trial simulation, model-based meta-analysis and the mechanism-based physiology-based pharmacokinetic modeling, and quantitative systems pharmacology. Expert commentary: Mechanism-based computer modeling rely less on existing clinical datasets, therefore can better generalize than Big Data analytics, including prospectively and quantitatively predicting the clinical outcome of new drugs. More specifically, exhaustive post-hoc analysis of failed trials using individual virtual human trial simulation could illuminate underlying causes such as lack of sufficient functional target engagement, negative pharmacodynamic interactions with comedications and genotypes, and mismatc...Continue Reading

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
May 30, 1996·Statistics in Medicine·X LiuY Stern
Aug 15, 1997·Neural Computation·M L Hines, N T Carnevale
Aug 14, 1997·Annals of the New York Academy of Sciences·R W Peck
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·N H HolfordC C Peck
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·P L Chan, N H Holford
Aug 17, 2002·Journal of Theoretical Biology·Leah Edelstein-keshet, Athan Spiros
Nov 18, 2011·Clinical Pharmacology and Therapeutics·J W MandemaM Pfister
Jul 24, 2012·Journal of Pharmacokinetics and Pharmacodynamics·James A RogersBrian Corrigan
Jan 23, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Hugo GeertsRobert Carr
Jan 1, 2012·CPT: Pharmacometrics & Systems Pharmacology·H GeertsR Carr
Feb 18, 2014·British Journal of Clinical Pharmacology·Holly Kimko, José Pinheiro
Jul 16, 2014·Alzheimer's Research & Therapy·Jeffrey L CummingsKate Zhong
Nov 21, 2014·PLoS Computational Biology·Yasser Iturria-MedinaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 12, 2015·Clinical Pharmacology and Therapeutics·K RomeroUNKNOWN Coalition Against Major Diseases
Feb 7, 2018·Journal of Psychiatric Research·Malgorzata MaciukiewiczJoseph Geraci
Feb 7, 2018·PloS One·Alexander StepanovTimothy Nicholas
Mar 23, 2018·The Journal of Pharmacology and Experimental Therapeutics·Eline M T van MaanenMeindert Danhof

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.